Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | -36.46%8.14M | 266.13%12.81M | 3.5M | ||
| Revenue from customers | ---- | --5.47M | ---- | ---- | ---- |
| Income from government grants | --3.97M | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | -43.13%4.17M | 109.68%7.34M | --3.5M | ---- | ---- |
| Cash paid | 24.44%-15.46M | -3.20%-20.47M | -51.05%-19.83M | -48.60%-13.13M | -8.84M |
| Payments to suppliers for goods and services | 24.44%-15.46M | -3.20%-20.47M | -51.05%-19.83M | -48.60%-13.13M | ---8.84M |
| Direct interest received | -59.08%48.01K | 325.59%117.32K | --27.57K | ---- | ---- |
| Operating cash flow | 3.48%-7.28M | 53.77%-7.54M | -24.19%-16.31M | -48.60%-13.13M | ---8.84M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 0 | 0 | 80.14%-112.19K | 89.35%-564.88K | -5.3M |
| Net PPE purchase and sale | ---- | ---- | ---- | 24.42%-12.29K | ---16.26K |
| Net intangibles purchas and sale | ---- | ---- | 78.65%-112.19K | 90.07%-525.57K | ---5.29M |
| Net investment purchase and sale | ---- | ---- | ---- | ---40K | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | 390.44%12.98K | --2.65K |
| Cash from discontinued investing activities | |||||
| Investing cash flow | --0 | --0 | 80.14%-112.19K | 89.35%-564.88K | ---5.3M |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 21.67%10.05M | 3,158.70%8.26M | -97.33%253.38K | -73.99%9.5M | 36.54M |
| Net issuance payments of debt | ---- | -2.34%-2.28M | 45.55%-2.23M | -11,916.85%-4.09M | ---34.01K |
| Net common stock issuance | -27.61%7.63M | 323.67%10.54M | -81.69%2.49M | -62.85%13.59M | --36.58M |
| Interest paid (cash flow from financing activities) | ---- | 1.83%-10.11K | ---10.3K | ---- | ---9.58K |
| Net other financing activities | --2.41M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 21.67%10.05M | 3,158.70%8.26M | -97.33%253.38K | -73.99%9.5M | --36.54M |
| Net cash flow | |||||
| Beginning cash position | 29.22%3.05M | -87.15%2.36M | -17.98%18.38M | 22,410,099.00%22.41M | --100 |
| Current changes in cash | 285.28%2.77M | 104.45%719.04K | -285.70%-16.16M | -118.71%-4.19M | --22.4M |
| Effect of exchange rate changes | -129.36%-65.8K | -119.69%-28.69K | -10.24%145.69K | 1,808.84%162.31K | --8.5K |
| End cash Position | 88.58%5.76M | 29.22%3.05M | -87.15%2.36M | -17.98%18.38M | --22.41M |
| Free cash from | 3.48%-7.28M | 54.09%-7.54M | -20.12%-16.42M | 3.36%-13.67M | ---14.14M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |